DOI QR코드

DOI QR Code

Cognitive outcomes in late childhood and adolescence of neonatal hypoxic-ischemic encephalopathy

  • Lee, Bo Lyun (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine) ;
  • Glass, Hannah C. (Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco)
  • 투고 : 2021.02.09
  • 심사 : 2021.05.18
  • 발행 : 2021.12.15

초록

Hypoxic-ischemic encephalopathy (HIE) is the most common cause of neonatal encephalopathy with a global incidence of approximately 1 to 8 per 1,000 live births. Neonatal encephalopathy can cause neurodevelopmental and cognitive impairments in survivors of hypoxic-ischemic insults with and without functional motor deficits. Normal neurodevelopmental outcomes in early childhood do not preclude cognitive and behavioral difficulties in late childhood and adolescence because cognitive functions are not yet fully developed at this early age. Therapeutic hypothermia has been shown to significantly reduced death and severe disabilities in term newborns with HIE. However, children treated with hypothermia therapy remain at risk for cognitive impairments and follow-up is necessary throughout late childhood and adolescence. Novel adjunctive neuroprotective therapies combined with therapeutic hypothermia may enhance the survival and neurodevelopmental outcomes of infants with HIE. The extent and severity of brain injury on magnetic resonance imaging might predict neurodevelopmental outcomes and lead to targeted interven tions in children with a history of neonatal encephalopathy. We provide a summary of the long-term cognitive outcomes in late childhood and adolescence in children with a history of HIE and the association between pattern of brain injury and neurodevelopmental outcomes.

키워드

참고문헌

  1. McIntyre S, Badawi N, Blair E, Nelson KB. Does aetiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy influence the outcome of treatment? Dev Med Child Neurol 2015;57 Suppl 3:2-7.
  2. Glass HC. Hypoxic-ischemic encephalopathy and other neonatal encephalopathies. Continuum (Minneap Minn) 2018;24:57-71. https://doi.org/10.1212/con.0000000000000557
  3. Perez A, Ritter S, Brotschi B, Werner H, Caflisch J, Martin E, et al. Longterm neurodevelopmental outcome with hypoxic-ischemic encephalopathy. J Pediatr 2013;163:454-9. https://doi.org/10.1016/j.jpeds.2013.02.003
  4. van Handel M, Swaab H, de Vries LS, Jongmans MJ. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr 2007;166:645-54. https://doi.org/10.1007/s00431-007-0437-8
  5. de Vries LS, Jongmans MJ. Long-term outcome after neonatal hypoxicischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2010;95:F220-4. https://doi.org/10.1136/adc.2008.148205
  6. Pappas A, Korzeniewski SJ. Long-term cognitive outcomes of birth asphyxia and the contribution of identified perinatal asphyxia to cerebral palsy. Clin Perinatol 2016;43:559-72. https://doi.org/10.1016/j.clp.2016.04.012
  7. Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, Truffert P. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed 2005;90:F257-61. https://doi.org/10.1136/adc.2003.047985
  8. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010;86:329-38. https://doi.org/10.1016/j.earlhumdev.2010.05.010
  9. Debillon T, Bednarek N, Ego A, LyTONEPAL Writing Group. LyTONEPAL: long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: a French population-based cohort. BMC Pediatr 2018;18:255. https://doi.org/10.1186/s12887-018-1232-6
  10. Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA, et al. Cognitive outcomes after neonatal encephalopathy. Pediatrics 2015;135:e624-34. https://doi.org/10.1542/peds.2014-1566
  11. Shapiro KA, Kim H, Mandelli ML, Rogers EE, Gano D, Ferriero DM, et al. Early changes in brain structure correlate with language outcomes in children with neonatal encephalopathy. Neuroimage Clin 2017;15:572-80. https://doi.org/10.1016/j.nicl.2017.06.015
  12. Robertson CM, Finer NN. Educational readiness of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Dev Behav Pediatr 1988;9:298-306.
  13. Robertson CM, Finer NN, Grace MGA. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr 1989;114:753-60. https://doi.org/10.1016/S0022-3476(89)80132-5
  14. Marlow N, Rose AS, Rands CE, Draper ES. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2005;90:F380-7. https://doi.org/10.1136/adc.2004.067520
  15. van Kooij BJM, van Handel M, Nievelstein RAJ, Groenendaal F, Jongmans MJ, de Vries LS. Serial MRI and neurodevelopmental outcome in 9- to 10-year-old children with neonatal encephalopathy. J Pediatr 2010;157:221-7. https://doi.org/10.1016/j.jpeds.2010.02.016
  16. van Handel M, de Sonneville L, de Vries LS, Jongmans MJ, Swaab H. Specific memory impairment following neonatal encephalopathy in term-born children. Dev Neuropsychol 2012;37:30-50. https://doi.org/10.1080/87565641.2011.581320
  17. Gadian DG, Aicardi J, Watkins KE, Porter DA, Mishkin M, Vargha-Khadem F. Developmental amnesia associated with early hypoxic-ischaemic injury. Brain 2000;123(Pt 3):499-507. https://doi.org/10.1093/brain/123.3.499
  18. Maneru C, Junque C, Botet F, Tallada M, Guardia J. Neuropsychological long-term sequelae of perinatal asphyxia. Brain Inj 2001;15:1029-39. https://doi.org/10.1080/02699050110074178
  19. Nagy Z, Lindstrom K, Westerberg H, Skare S, Andersson J, Hallberg B, et al. Diffusion tensor imaging on teenagers, born at term with moderate hypoxic-ischemic encephalopathy. Pediatr Res 2005;58:936-40. https://doi.org/10.1203/01.pdr.0000186516.85702.61
  20. Lindstrom K, Lagerroos P, Gillberg C, Fernell E. Teenage outcome after being born at term with moderate neonatal encephalopathy. Pediatr Neurol 2006;35:268-74. https://doi.org/10.1016/j.pediatrneurol.2006.05.003
  21. Lee B, Gano G, Rogers EE, Xu D, Cox S, Barkovich AJ, et al. Long-term cognitive outcomes in term newborns with watershed injury caused by neonatal encephalopathy. Pediatr Res Forthcoming 2021.
  22. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013;2013:Cd003311.
  23. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1574-84. https://doi.org/10.1056/NEJMcps050929
  24. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361:1349-58. https://doi.org/10.1056/NEJMoa0900854
  25. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010;340:c363. https://doi.org/10.1136/bmj.c363
  26. Zhou WH, Cheng GQ, Shao XM, Liu XZ, Shan RB, Zhuang DY, et al. Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J Pediatr 2010;157:367-72. https://doi.org/10.1016/j.jpeds.2010.03.030
  27. Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med 2011;165:692-700. https://doi.org/10.1001/archpediatrics.2011.43
  28. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-70. https://doi.org/10.1016/S0140-6736(05)70932-6
  29. Simbruner G, Mittal RA, Rohlmann F, Muche R. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 2010;126:e771-8. https://doi.org/10.1542/peds.2009-2441
  30. Papile LA, Baley JE, Benitz W, Cummings J, Carlo WA, Eichenwald E, et al. Hypothermia and neonatal encephalopathy. Pediatrics 2014;133:1146-50. https://doi.org/10.1542/peds.2014-0899
  31. Shankaran S, Laptook AR, Pappas A, McDonald SA, Das A, Tyson JE, et al. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA 2014;312:2629-39. https://doi.org/10.1001/jama.2014.16058
  32. hankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012;366:2085-92. https://doi.org/10.1056/NEJMoa1112066
  33. Azzopardi D, Strohm B, Marlow N, Brocklehurst P, Deierl A, Eddama O, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014;371:140-9. https://doi.org/10.1056/NEJMoa1315788
  34. Guillet R, Edwards AD, Thoresen M, Ferriero DM, Gluckman PD, Whitelaw A, et al. Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy. Pediatr Res 2012;71:205-9. https://doi.org/10.1038/pr.2011.30
  35. Oorschot DE, Sizemore RJ, Amer AR. Treatment of neonatal hypoxic-ischemic encephalopathy with erythropoietin alone, and erythropoietin combined with hypothermia: history, current status, and future research. Int J Mol Sci 2020;21;1487. https://doi.org/10.3390/ijms21041487
  36. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med 2012;166:558-66. https://doi.org/10.1001/archpediatrics.2011.1772
  37. McAdams RM, Juul SE. Neonatal encephalopathy: update on therapeutic hypothermia and other novel therapeutics. Clin Perinatol 2016;43:485-500. https://doi.org/10.1016/j.clp.2016.04.007
  38. Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 2014;164:973-9. https://doi.org/10.1016/j.jpeds.2013.11.036
  39. Aly H, Elmahdy H, El-Dib M, Rowisha M, Awny M, El-Gohary T, et al. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 2015;35:186-91. https://doi.org/10.1038/jp.2014.186
  40. Azzopardi D, Robertson NJ, Bainbridge A, Cady E, Charles-Edwards G, Deierl A, et al. Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol 2016;15:145-53. https://doi.org/10.1016/S1474-4422(15)00347-6
  41. Wu YW, Mathur AM, Chang T, McKinstry RC, Mulkey SB, Mayock DE, et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial. Pediatrics 2016;137:e20160191. https://doi.org/10.1542/peds.2016-0191
  42. Filippi L, Fiorini P, Catarzi S, Berti E, Padrini L, Landucci E, et al. Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study. J Matern Fetal Neonatal Med 2018;31:973-80. https://doi.org/10.1080/14767058.2017.1304536
  43. Juul SE, Comstock BA, Heagerty PJ, Mayock DE, Goodman AM, Hauge S, et al. High-dose erythropoietin for asphyxia and encephalopathy (HEAL): a randomized controlled trial - background, aims, and study protocol. Neonatology 2018;113:331-8. https://doi.org/10.1159/000486820
  44. Rangarajan V, Juul SE. Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol 2014;51:481-8. https://doi.org/10.1016/j.pediatrneurol.2014.06.008
  45. Lobo N, Yang B, Rizvi M, Ma D. Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy? J Neurosci Res 2013;91:473-8. https://doi.org/10.1002/jnr.23178
  46. Ruegger CM, Davis PG, Cheong JL. Xenon as an adjuvant to therapeutic hypothermia in near-term and term newborns with hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev 2018;8:Cd012753.
  47. Alonso-Alconada D, Alvarez A, Arteaga O, Martinez-Ibarguen A, Hilario E. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 2013;14:9379-95. https://doi.org/10.3390/ijms14059379
  48. Sanchez Fernandez I, Morales-Quezada JL, Law S, Kim P. Prognostic value of brain magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy: a meta-analysis. J Child Neurol 2017;32:1065-73. https://doi.org/10.1177/0883073817726681
  49. Miller SP, Ramaswamy V, Michelson D, Barkovich AJ, Holshouser B, Wycliffe N, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 2005;146:453-60. https://doi.org/10.1016/j.jpeds.2004.12.026
  50. Steinman KJ, Gorno-Tempini ML, Glidden DV, Kramer JH, Miller SP, Barkovich AJ, et al. Neonatal watershed brain injury on magnetic resonance imaging correlates with verbal IQ at 4 years. Pediatrics 2009;123:1025-30. https://doi.org/10.1542/peds.2008-1203
  51. Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen F, et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol 1998;19:143-9.
  52. Kaufman SA, Miller SP, Ferriero DM, Glidden DH, Barkovich AJ, Partridge JC. Encephalopathy as a predictor of magnetic resonance imaging abnormalities in asphyxiated newborns. Pediatr Neurol 2003;28:342-6. https://doi.org/10.1016/S0887-8994(03)00015-8
  53. Roland EH, Poskitt K, Rodriguez E, Lupton BA, Hill A. Perinatal hypoxic-ischemic thalamic injury: clinical features and neuroimaging. Ann Neurol 1998;44:161-6. https://doi.org/10.1002/ana.410440205
  54. Barnett A, Mercuri E, Rutherford M, Haataja L, Frisone MF, Henderson S, et al. Neurological and perceptual-motor outcome at 5 - 6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. Neuropediatrics 2002;33:242-8. https://doi.org/10.1055/s-2002-36737
  55. de Vries LS, Cowan FM. Evolving understanding of hypoxic-ischemic encephalopathy in the term infant. Semin Pediatr Neurol 2009;16:216-25. https://doi.org/10.1016/j.spen.2009.09.001